Tecan Group Ltd. (SIX Swiss Exchange: TECN) has successfully placed 650,000 new registered shares in a private placement by way of an accelerated bookbuilding and completed a capital increase of approx. CHF 360 million to partially refinance the acquisition of Paramit Corporation. The offer price was set at CHF 550 per share. Credit Suisse Ltd. …
The shareholders of Montana Capital Partners, a European-based private equity secondaries asset manager, have entered into a share purchase agreement regarding the sale of all shares to PGIM, the global investment management business of Prudential Financial, Inc. Completion is subject to regulatory approval.
Bär & Karrer advises Triton Fund V advised by Triton on the acquisition of Swiss IT Security Group, a leading cyber security services provider in the DACH and Benelux regions, from Ufenau Capital Partners. The transaction is subject to regulatory approvals.
Deutsche Börse AG acquires a majority stake in Crypto Finance AG, a financial group under consolidated FINMA supervision that offers trading, storage, and investment in digital assets to institutional and professional clients.
The SIX Swiss Exchange listed Tecan Group entered into an agreement to acquire US-based Paramit Corporation for a total purchase consideration of USD 1.0 billion. Paramit, headquartered in Morgan Hill (California/USA), is a leading OEM developer and manufacturer of medical devices and life sciences instruments.
Deutsche Börse AG acquires the remaining 49% stake in Clearstream Fund Centre AG from UBS AG for CHF 390 million and becomes the sole shareholder of Clearstream Fund Centre, a leading European fund distribution platform. The acquisition of the initial 51% stake had closed on 30 September 2020.
Doctors and laboratory specialists, together with the investment firm GENUI, acquired labor team w ag, one of the leading private medical laboratories in Switzerland. The laboratory provides professional services for the prevention, diagnosis, monitoring and treatment of diseases throughout Switzerland.
Today, Lonza and Sanofi announced that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The large-scale facility will be established through a joint venture with an initial investment of around CHF 290 million shared equally between Lonza and Sanofi. …
The owners of Fostag Formenbau AG (FOSTAG), a leading manufacturer of high performance injection moulds for medical, thin wall packaging and closure applications, have sold a majority in FOSTAG to a group of Swiss private investors led by BLR Partners.
The leading global schools group Cognita, whose majority owner is Jacobs Holding, has acquired a majority stake in the Swiss-based Obersee Bilingual School (OBS). With provision from nursery to Matura, OBS bilingually educates currently 375 children and young people of the international community in Schwyz. The school offers the IB curriculum and the Swiss Matura.